Vaccines
Nobel Prize in Physiology and Medicine 2023
Nobel Prize in Physiology and Medicine 2023

Recognition of contributions leading to an unprecedented pace of vaccine development.

June 2024

FDA Evaluation of Updated COVID-19 Vaccines
FDA Evaluation of Updated COVID-19 Vaccines

The FDA evaluates updated monovalent vaccines for COVID-19, specifically for the Pfizer and Moderna mRNA vaccines, considering the prevalence of the most recent variant.

May 2024

FDA Approval of Updated Novarax Vaccine
FDA Approval of Updated Novarax Vaccine

Authorization of an updated Novarax vaccine for individuals aged 12 and older, featuring modifications to include spike protein from the SARS-CoV-2 omicron variant lineage XBB.1.5.

May 2024

COVID-19: Effectiveness of Non-Pharmaceutical Inte
COVID-19: Effectiveness of Non-Pharmaceutical Interventions Examined

Effective implementation of non-pharmaceutical interventions buys time to enable the development and manufacturing of drugs and vaccines, highlighting the importance of public health measures in controlling the spread of COVID-19.

May 2024

The US Approves a Vaccine for Pregnant Women Again
The US Approves a Vaccine for Pregnant Women Against RSV

Abrysvo, from Pfizer, is approved for use in pregnant women to protect infants during their first six months of life against respiratory syncytial virus (RSV), expanding the available options for maternal immunization.

April 2024

WHO Warns of ’Worrying Trends’ in COVID-19 Cas
WHO Warns of ’Worrying Trends’ in COVID-19 Cases

The WHO has raised concerns about increasing COVID-19 cases and urged booster vaccinations to mitigate potential worsening, especially with the onset of cold weather.

April 2024

Arexvy Vaccine Receives European Commission Approv
Arexvy Vaccine Receives European Commission Approval for RSV

The Arexvy vaccine, previously approved by the FDA in the US, receives European Commission approval for respiratory syncytial virus (RSV) prevention, with initial doses expected in the fall.

Februery 2024

Promising Results for Chikungunya Fever Vaccine
Promising Results for Chikungunya Fever Vaccine

VLA1553, the first vaccine against chikungunya fever, induces antibody production in 99% of patients, offering hope in the fight against the disease.

Februery 2024

Celebrating a Century of BCG Vaccine: Insights int
Celebrating a Century of BCG Vaccine: Insights into Tuberculosis Prevention

The BCG vaccine’s enduring legacy in tuberculosis prevention underscores its significance in public health, particularly amidst the challenges posed by the COVID-19 pandemic.

Februery 2024

Novel Equation Proposed for Equitable Allocation o
Novel Equation Proposed for Equitable Allocation of Health Resources

A new formula has been proposed to assist health systems in 174 countries in making decisions regarding the incorporation of drugs, devices, and vaccines. Published in The Lancet Global Health, this study aims to streamline resource allocation and ensure equitable access to essential healthcare resources worldwide.

January 2024